DGNS Relative Valuation - Diagnos Laboratorium Utama PT Tbk

Watchlist Manager

Watchlist

Price: 302 IDR -0.66% Market Closed

Market Cap: Rp377.5B

D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	ID
F	Filinvest Development Corp XPHS:FDC	PH
	Eumundi Group Ltd ASX:EBG	AU
	Parkway Life Real Estate Investment Trust SGX:C2PU	SG
	Super Crop Safe Ltd BSE:530883	IN
	Silvercrest Asset Management Group Inc NASDAQ:SAMG	US
H	Hindustan Composites Ltd NSE:HINDCOMPOS	IN
W	Western Region Gold Co Ltd SSE:601069	CN
D	Dong-A ST Co Ltd KRX:170900	KR
	Nanovibronix Inc NASDAQ:NAOV	US
N	Nippon Seiro Co Ltd TSE:5010	JP
A	Adventa Bhd KLSE:ADVENTA	MY
G	Gloster Ltd BSE:542351	IN
R	Ronesans Gayrimenkul Yatirim AS IST:RGYAS.E	TR
	Fuji Oozx Inc TSE:7299	JP
V	Vitzro Tech Co Ltd KOSDAQ:042370	KR
C	Ching Lee Holdings Ltd HKEX:3728	HK
	HMS Networks AB STO:HMS	SE
N	Nexxen International Ltd LSE:NEXN	IL
	Greenlane Renewables Inc TSX:GRN	CA
	Ashtead Group PLC LSE:AHT	UK
H	H P Cotton Textile Mills Ltd BSE:502873	IN

Multiples-Based Value

The Multiples-Based Value of one DGNS stock under the Base Case scenario is hidden IDR. Compared to the current market price of 302 IDR, Diagnos Laboratorium Utama PT Tbk is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

DGNS Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	377.5B IDR	1.3	-198.4	-6 312.2	-6 312.2
US		CVS Health Corp NYSE:CVS	91.3B USD	0.2	51.6	13.5	13.5
US	C	Cigna Group XMUN:CGN	66.4B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	70.3B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25B EUR	1.1	19.7	9.3	13.9
DE		Fresenius Medical Care AG XMUN:FME	22.9B EUR	1.2	23.4	9	16.7
US		Quest Diagnostics Inc NYSE:DGX	21.6B USD	2	21.8	11.8	15.9
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	25	12	17.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8B EUR	0.5	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	12.1B USD	12.3	-29	-31.7	-28.8
US		DaVita Inc NYSE:DVA	10.5B USD	0.8	14.1	7.2	9.8

				Revenue Growth	P/S to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/S: 2 1.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	12.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/E: 21.3 Negative Multiple: -198.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	51.6	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.7	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.4	16%	1.5
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
US		Laboratory Corporation of America Holdings NYSE:LH	25	27%	0.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29	N/A	N/A
US		DaVita Inc NYSE:DVA	14.1	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBITDA: 9.5 Negative Multiple: -6 312.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -31.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBIT: 13.3 Negative Multiple: -6 312.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.9	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.7	11%	1.5
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.8	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk IDX:DGNS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors